aycan workstation OsiriX PRO is a software device intended for viewing of images acquired from CT, MR, CR, DR, US and other DICOM compliant medical imaging systems when installed on suitable commercial standard hardware.

Images and data can be captured, stored, communicated, processed, and displayed within the system and or across computer networks at distributed locations.

Lossy compressed mammographic images and digitized film screen images must not be reviewed for primary diagnosis or image interpretation. For primary diagnosis, post process DICOM "for presentation" images must be used. Mammographic images should only be viewed with a monitor approved by FDA for viewing mammographic images.

It is the User's responsibility to ensure monitor quality, ambient light conditions, and image compression ratios are consistent with clinical application.

Device Description

The aycan workstation OsinX PRO provides services for review and post processing of diagnostic medical images and information. It conforms to the DICOM 3.0 standard to allow the sharing of medical information with other digital imaging systems. aycan workstation OsiriX PRO runs on Apple Mac OSX systems and provides high performance review, navigation and post processing functionality for multidimensional and multimodality images.

aycan workstation OsiriX PRO is a software device that handles and manipulates digital medical images.

AI/ML Overview

The provided text is a 510(k) Summary for the aycan workstation OsiriX PRO. It outlines the device's characteristics and its substantial equivalence to a predicate device, but it does not contain a detailed study report with specific acceptance criteria and performance data for the device itself.

Here's a breakdown of what can and cannot be extracted from the provided document based on your request:

1. A table of acceptance criteria and the reported device performance

Acceptance Criteria: Not explicitly stated in terms of measurable performance metrics. The document broadly states "the predetermined acceptance criteria were met" and "The system passed all testing criteria," but the criteria themselves are not defined or quantified.
Reported Device Performance: Not provided. There are no performance metrics or results (e.g., accuracy, sensitivity, specificity) for the aycan workstation OsiriX PRO.

2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective)

Sample Size: Not mentioned.
Data Provenance: Not mentioned.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience)

Not mentioned. The document primarily focuses on regulatory approval and device description, not on detailed clinical validation studies.

4. Adjudication method (e.g., 2+1, 3+1, none) for the test set

Not mentioned.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not mentioned. The document describes the device as a "software device intended for viewing of images acquired from CT, MR, CR, DR, US and other DICOM compliant medical imaging systems." It is a Picture Archiving Communications System (PACS) and an image processing system. There is no indication of AI assistance or a comparative effectiveness study involving human readers.

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done

The device described is a PACS workstation, not an AI algorithm. Its function is to display and process images for human interpretation, explicitly stating, "A physician, providing ample opportunity for competent human intervention interprets images and information being displayed and printed." Therefore, a standalone algorithm-only performance study would not be applicable or relevant to this device's stated function.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

Not mentioned.

8. The sample size for the training set

Not mentioned. As this is not an AI/ML algorithm that typically requires a training set, this information is not expected.

9. How the ground truth for the training set was established

Not mentioned. (See point 8)

Summary of available information regarding acceptance criteria and study:

The document states:

"As required by the risk analysis, designated individuals performed all verification and validation activities and results demonstrated that the predetermined acceptance criteria were met. The system passed all testing criteria." (K103546, P. 2)

This indicates that internal verification and validation were conducted, and the device met its internal acceptance criteria. However, the specific details of these criteria, the study design, sample sizes, ground truth establishment, or any performance metrics are not included in this 510(k) summary. The summary focuses on demonstrating substantial equivalence to a predicate device based on its functional characteristics and intended use, rather than a detailed performance study like what would be expected for a diagnostic AI device.

Summary

{0}------------------------------------------------

K103546
P. 1 of 2

510(k) Summary of Safety and Effectiveness

This 510(k) summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990.

Date Prepared:

November 24, 2010

MAR 1 7 2011

Submitter's Information: 21 CFR 807.92(a)(1)

Mr. Matthias Broenner aycan Digitalsysteme GmbH Innere Aumuehlstr. 5 97076 Wurerzburg Germany

Trade Name, Common Name and Classification: 21 CFR 807.92(a)(2)

Trade Name:	aycan workstation OsiriX PRO
Common Name:	Picture Archiving Communications System
Classification Name:	system, image processing, radiological
Product code:	LLZ

Predicate Device: 21 CFR 807. 92(a)(3)

FDA has classified the predicate device (K063470) as Class II, CFR 892.2050, LLZ. It is our understanding that aycan Workstation Osin'X device falls under the same classification as the predicate device. Predicate device details are as follows:

Device Classification Name:	system, image processing, radiological
510(k) Number:	K063470
Regulation Number:	892.2050
Device Name:	aycan workstation OsiriX
Applicant:	aycan Digitalsysteme GmbHInnere Aumuehlstr. 597076 WuerzburgGermany
Classification Product Code:	LLZ
Decision Date:	01/05/2007
Classification Advisory Committee:	Radiology

Device Description: 21 CFR 807 92(a)(4)

{1}------------------------------------------------

K103546
P. 2 of 2

PRO runs on Apple Mac OSX systems and provides high performance review, navigation and post processing functionality for multidimensional and multimodality images.

Indications for Use: 21-CFR-807-92(a)(5)--------------------------------------------------------------------------------------------------------------------------------------

Images and data can be captured, stored, communicated, processed, and displayed within the system and or across computer networks at distributed locations.

It is the User's responsibility to ensure monitor quality, ambient light conditions, and image compression ratios are consistent with clinical application.

Technological Characteristics: 21 CFR 807 92(a)(6)

aycan workstation OsiriX PRO is a software device that handles and manipulates digital medical images.

The device does not contact the patient, nor does it control any life sustaining devices. A physician, providing ample opportunity for competent human intervention interprets images and information being displayed and printed.

Testing

ﺃﺭ ﻣﺮﺍﺟﻊ ﺃﻭ

As required by the risk analysis, designated individuals performed all verification and validation activities and results demonstrated that the predetermined acceptance criteria were met. The system passed all testing criteria.

Conclusion: 21 CFR 807 92(b)(1)

The 510(k) Pre-Market Notification for aycan workstation OsiriX PRO contains adequate information and data to enable FDA - CDRH to determine substantial equivalence to the predicate device.

The submission contains the results of a hazard analysis and the "Level of Concern" for potential hazards has been classified as "Moderate".

{2}------------------------------------------------

Image /page/2/Picture/0 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a stylized eagle with its wings spread, symbolizing protection and service. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the eagle.

DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -- WO66-G609 Silver Spring, MD 20993-0002

Mr. Matthias Broenner Quality and Regulations Manager aycan Digitalsysteme GmbH Innere Aumuehlstr. 5 97076 Wuerzburg GERMANY

MAR 1 7 201

Re: K103546

Trade/Device Name: aycan workstation OsiriX PRO Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: November 24, 2010 Received: December 2, 2010

Dear Mr. Broenner:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of

{3}------------------------------------------------

medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely Yours,

Mary Pastel

Mary S. Pastel, Sc.D. Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Indications for Use Form

510(k) Number:

Device Name: aycan workstation OsiriX PRO

Indications for Use:

Images and data can be captured, stored, communicated, processed, and displayed within the system and or across computer networks at distributed locations.

It is the User's responsibility to ensure monitor quality, ambient light conditions, and image compression ratios are consistent with clinical application.

Prescription Use (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Macy Shattle

Division of Radiologic Office of In Vitro

510K K103546

Page 1 of /

Regulation Number and Section

§ 892.2050 Medical image management and processing system.

(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).